Delivery Order SPE2DB22D1017-SPE2DB25FF3EX

Award Date 1/15/25
Potential Completion Date 1/16/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with an ID of SPE2DB22D3401|SPE2DB25FT0NM, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,484.26 firm fixed-price delivery order is for the supply of 4,566,307,481 units of the medication dicyclomine 20 mg tablet. The contract has an ultimate completion date of November 4, 2024 and does not have a set-aside designation, indicating open competition....
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) under an Indefinite Delivery Contract (IDC) valued at $999,999,999. The contract, which runs through November 2026, provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The awarded delivery order, valued at $2,843.27, is for 4,567,556,214 dicyclomine 20 mg tablets. This contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,367.54 firm fixed-price delivery order is for the supply of 4,564,897,937 units of 20 mg Dicyclomine tablets. This award is not associated with any set-aside designation. The contract serves as a delivery order under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,545,088 units of 20 mg/2 mL dicyclomine vials, a medication used to treat gastrointestinal issues. The contract has a ceiling value of $1,280.23 and a completion date of November 26, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award, valued at $3,982.91, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of 4,562,240 units of the medication dicyclomine 20 mg tablets, with a completion date of September 21, 2023. The contract is a delivery order awarded under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc., doing business as Amerisourcebergen,...
This federal contract award is for the delivery of Dicyclomine 20 mg/2 ml ampul 2 ml, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $4,001.52 and was awarded to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order, with a firm fixed price pricing type, and has a completion date of December 15, 2022. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...
This federal contract award, valued at $1,640.88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567568843 - DICYCLOMINE 20 MG/2 ML VIAL 2ML, a medical product, and is a Firm Fixed Price Delivery Order. The contract has an ultimate completion date of March 14, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $8,037.56, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4560904783 - DICYCLOMINE 20 MG/2 ML VIAL 2ML. The contract is a delivery order type with a firm fixed price, and the ultimate completion date is May 12, 2023. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies....
This federal contract award, valued at $44,147.49, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under the company's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999.00 and runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of...
This federal contract award, valued at $23,738.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the DLA's Indefinite Delivery Contract (IDC) with Amerisourcebergen, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FF3EX
    Delivery Order

This federal contract award, with ID SPE2DB22D1017|SPE2DB25FF3EX, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of 4,566,947,260 units of the drug Dicyclomine 20 mg tablets. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,054.49 and a period of performance running through January 16, 2025. The contract does not have a set-aside designation, indicating open competition. As a large pharmaceutical distribution company, Amerisourcebergen holds significant Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation, valued at $999,999,999 and $750,000 respectively, for providing a comprehensive range of pharmaceutical products and medical supplies to support federal healthcare programs.

Generated 5/21/25, 10:37 AM